Please use this identifier to cite or link to this item:
|Title:||Plasminogen activator inhibitor-2 is expressed in different types of congenital ichthyosis: In vivo evidence for its cross-linking into the cornified cell envelope by transglutaminase-1|
|Keywords:||Cornified cell envelope|
|Source:||Oji, V., Oji, M.E., Adamini, N., Walker, T., Aufenvenne, K., Raghunath, M., Traupe, H. (2006-05). Plasminogen activator inhibitor-2 is expressed in different types of congenital ichthyosis: In vivo evidence for its cross-linking into the cornified cell envelope by transglutaminase-1. British Journal of Dermatology 154 (5) : 860-867. ScholarBank@NUS Repository. https://doi.org/10.1111/j.1365-2133.2005.07109.x|
|Abstract:||Background: Plasminogen activator inhibitor-2 (PAI-2), a regulatory serpin of the plasminogen activator (PA) system, has been described as a potential component of the cornified cell envelope (CE). Protease inhibitors are essential for skin homeostasis and in particular for the regulation of the desquamation process. Therefore, an aberrant expression of PAI-2 could be involved in the pathogenesis of certain cornification disorders. Objectives: Evaluation of the expression of PAI-2 in different types of congenital ichthyosis, especially in lamellar ichthyosis/nonbullous congenital ichthyosiform erythroderma (LI/NCIE) and in Netherton syndrome (NTS). Demonstration of the functional relationship between PAI-2 and transglutaminase (TGase)-1. Patients and methods: Using immunohistochemistry we evaluated cryosections from individuals suffering from LI/NCIE (n = 67), NTS (n = 6), ichthyosis-follicularis-atrichia-photophobia syndrome (n = 2) and Harlequin ichthyosis (n = 1) in comparison with psoriasis vulgaris and healthy skin. Moreover, we assessed the respective TGase-1 activity and the presence of TGase-1 protein. A functional assay was developed to elucidate whether PAI-2 is a substrate for TGase-1. Results: PAI-2 is expressed in different types of congenital ichthyosis and there is a strong correlation between TGase-1 activity and PAI-2 protein signal. Double staining revealed a strong colocalization of TGase-1 activity and PAI-2 protein. The epidermal incorporation of the specific PAI-2 peptide containing a TGase binding site revealed a strong pericellular staining in the stratum granulosum in healthy skin. In contrast, TGase-1-deficient skin showed only a lamellar staining in the stratum corneum. Conclusions: We provide in vivo evidence that PAI-2 is a substrate of TGase-1. The normal expression of PAI-2 in a large group of TGase-1-proficient LI/NCIE patients makes it rather unlikely that PAI-2 alone is a primary molecular cause of LI/NCIE. © 2006 British Association of Dermatologists.|
|Source Title:||British Journal of Dermatology|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Dec 7, 2017
WEB OF SCIENCETM
checked on Nov 22, 2017
checked on Dec 17, 2017
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.